The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naïve prostate cancer patients with bone metastases: Results of ZAPCA study.
 
Tomomi Kamba
No Relationships to Disclose
 
Toshiyuki Kamoto
Honoraria - Astellas Pharma
 
Yousuke Shimizu
No Relationships to Disclose
 
Shunichi Namiki
No Relationships to Disclose
 
Kiyohide Fujimoto
No Relationships to Disclose
 
Hiroaki Kawanishi
No Relationships to Disclose
 
Fuminori Sato
No Relationships to Disclose
 
Shintaro Narita
No Relationships to Disclose
 
Takefumi Satoh
No Relationships to Disclose
 
Hideo Saito
No Relationships to Disclose
 
Mikio Sugimoto
No Relationships to Disclose
 
Jun Teishima
No Relationships to Disclose
 
Naoya Masumori
No Relationships to Disclose
 
Shin Egawa
Honoraria - Astellas Pharma; AstraZeneca; Takeda
 
Hideki Sakai
Honoraria - Astellas Pharma; AstraZeneca; GlaxoSmithKline; Novartis; Takeda
 
Yusaku Okada
No Relationships to Disclose
 
Toshiro Terachi
Consulting or Advisory Role - TERUMO
Research Funding - Takeda
 
Osamu Ogawa
Honoraria - Astellas Pharma